Curaleaf Holdings (CURLF) Operating Leases (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Operating Leases of $102.3 million for Q4 2025, down 3.62% year-on-year from $106.2 million in Q4 2024, and down 3.62% on a QoQ basis from $106.2 million in Q4 2024.

Curaleaf Holdings (CURLF) Operating Leases (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Operating Leases for 7 consecutive years, with $102.3 million the latest figure, recorded in Q4 2025.

  • Quarterly Operating Leases fell 3.62% year-over-year to $102.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $102.3 million (down 3.62% YoY) and the FY2025 annual result came in at $102.3 million, down 3.62% from the prior year.
  • Operating Leases slipped to $102.3 million in Q4 2025 per CURLF's latest filing, from $106.2 million in the prior quarter.
  • Over the last five years, Operating Leases for CURLF reached as high as $322.0 billion in Q1 2022 and fell as low as $65.5 million in Q4 2021.
  • A 5-year average of $21.6 billion and a median of $112.6 million in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2021 — Operating Leases slumped 75.79% — and 2022, when it jumped 118732.03%.
  • Year by year, Operating Leases stood at $65.5 million in 2021, then surged by 72.99% to $113.3 million in 2022, then fell by 2.57% to $110.4 million in 2023, then declined by 3.81% to $106.2 million in 2024, then dropped by 3.62% to $102.3 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods registered $102.3 million, $106.2 million, and $108.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 102.35 Mn
Dec 31, 2024 106.19 Mn
Sep 30, 2024 108.71 Mn
Jun 30, 2024 109.85 Mn
Dec 31, 2023 110.40 Mn
Sep 30, 2023 109.50 Mn
Jun 30, 2023 112.57 Mn
Dec 31, 2022 113.31 Mn
Sep 30, 2022 400.40 Mn
Jun 30, 2022 378.58 Mn
Mar 31, 2022 321.97 Bn
Dec 31, 2021 65.50 Mn
Sep 30, 2021 291.33 Mn
Jun 30, 2021 293.19 Mn
Mar 31, 2021 270.95 Mn
Dec 31, 2020 270.50 Mn
Sep 30, 2020 259.22 Mn
Dec 31, 2019 81.32 Mn